LOPEZ DAVID L 4
4 · DISCOVERY LABORATORIES INC /DE/ · Filed Sep 29, 2010
Insider Transaction Report
Form 4
LOPEZ DAVID L
Executive VP & Legal Counsel
Transactions
- Award
Common Stock
2010-09-27+225,000→ 278,834 total
Holdings
- 38,385(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]New Restricted Stock Award Shall fully vest upon the earlier of (i) the second anniversary of the date of grant (ii) approval of Discovery Labs New Drug Application for Surfaxin (R) for the prevention of RDS or (iii) the effective date of a strategic alliance, collaboration agreement or other similar arrangement between Discovery Labs and one of more third parties providing for the support for the development and/or commercialization of one or more of Discovery Lab's lead research and development programs - Surfaxin (R), Surfaxin (TM), and Aerosurf (R).
- [F2]Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan.